Miki Y, Swensen J, Shattuck-Eidens D, Futrea PA, Harshman K, Tavigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.
PubMed
CAS
Article
Google Scholar
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.
PubMed
CAS
Article
Google Scholar
Nomizu T, Tsuchiya A, Kanno M, Katagata N, Watanabe F, Yamaki Y, et al. Clinicopathological features of hereditary breast cancer. Breast Cancer. 1997;4:239–42.
PubMed
Article
Google Scholar
Nomizu T, Abe R, Tsuchiya A, Utsunomiya J, Watanabe F, Yamaki Y. A clinical study of familial cancer in Japan. In: Weber W, editor. Familial cancer control. European School of Oncology Monographs. Berlin: Springer; 1992. p. 105–11.
Chapter
Google Scholar
Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–90.
PubMed
CAS
Article
Google Scholar
Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, et al. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet. 2005;42(3):e20.
PubMed
CAS
Article
PubMed Central
Google Scholar
Ramus SJ, Friedman LS, Gayther SA, Ponder BA, Bobrow L, van der Looji M, et al. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Nat Genet. 1997;15:14–5.
PubMed
CAS
Article
Google Scholar
Liede A, Rehal P, Vesprini D, Jack E, Abrahamson J, Narod S. A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. Am J Hum Genet. 1998;62:1543–4.
PubMed
CAS
Article
PubMed Central
Google Scholar
Friedman E, Bruchim RBS, Kruglikova A, Risel S, Levy-Lahad E, Halle D, et al. Double heterozygotes for the Ashkenazi founder mutation in BRCA1 and BRCA2 genes. Am J Hun Genet. 1998;63:1224–7.
CAS
Article
Google Scholar
Loader S, Rowley PT. Deleterious mutations of both BRCA1 and BRCA2 in three siblings. Genet Test. 1998;2:75–7.
PubMed
CAS
Article
Google Scholar
Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient. Gynecol Oncol. 1998;70:432–4.
PubMed
CAS
Article
Google Scholar
Tesoriero A, Andersen C, Southey M, Somers G, McKay M, Armes J, et al. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet. 1999;65:567–9.
PubMed
CAS
Article
PubMed Central
Google Scholar
Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet. 2000;66:1259–72.
PubMed
CAS
Article
PubMed Central
Google Scholar
Bell DW, Erban J, Sgroi DC, Haber DA. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res. 2002;62:2741–3.
PubMed
CAS
Google Scholar
Caldes T, de la Hoya M, Tosar A, Sulleiro S, Godino J, Ibanez D, et al. A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes. J Med Genet. 2002;39:e44.
PubMed
CAS
Article
PubMed Central
Google Scholar
Claus EB, Petruzella S, Matloff E, Carter D. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA. 2005;293:964–9.
PubMed
CAS
Article
Google Scholar
Smith M, Fawcett S, Sigalas E, Bell R, Devery S, Andrieska N, et al. Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes. Fam Cancer. 2008;7:119–24.
PubMed
CAS
Article
Google Scholar
Steffensen AY, Jønson L, Ejlertsen B, Gerdes AM, Nielsen FC, Hansen TVO. Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations. Fam Cancer. 2010;9:283–7.
PubMed
CAS
Article
PubMed Central
Google Scholar
Zuradelli M, Peissel B, Manoukian S, Zaffaroni D, Barile M, Pensotti V, et al. Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics. Breast Cancer Res Treat. 2010;124:251–8.
PubMed
CAS
Article
Google Scholar
Pilato B, De Summa S, Danza K, Lambo R, Paradiso A, Tommasi S. Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report. Breast Cancer Res Treat. 2010;124:875–8.
PubMed
Article
Google Scholar
Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O, et al. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol. 2011;22:964–6.
PubMed
CAS
Article
PubMed Central
Google Scholar
Heidemann S, Fischer C, Engel C, Fischer B, Harder L, Schlegelberger B, et al. Double heterozygosity for mutation in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat. 2012;134:1229–39.
PubMed
CAS
Article
Google Scholar
Choi DH, Lee MH, Haffty BG. Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes. Breast J. 2006;12:216–20.
PubMed
CAS
Article
Google Scholar
Noh JM, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW, et al. Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. Breast Cancer Res Treat. 2012;131:217–22.
PubMed
CAS
Article
Google Scholar
Sugano K, Nakamaura S, Ando J, Takayama S, Kamata H, Sekiguchi I, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci. 2008;99:1967–76.
PubMed
CAS
Article
Google Scholar
Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. Med Gen Med. 2005;7(2):60.
Google Scholar